Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mixed Data Cloud Future Of Sunovion's ADHD Drug
Jan 17 2017
•
By
Lucie Ellis-Taitt
Sunovion Will Target ADHD As Dasotraline's First Regulatory Filing • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D